Keywords: antiangiogenics; chemotherapy; epithelial ovarian cancer; PARP inhibitors; targeted therapeutics;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: Degeneración macular asociada a la edad; AngiografÃa; TomografÃa de coherencia óptica; Neovascularización coroidea; Atrofia geográfica; Antiangiogénicos; Age-related macular degeneration; Angiography; Optical coherence tomography; Choroidal neovasc
Keywords: Age-related macular degeneration; Angiography; Optical coherence tomography; Choroidal neovascularization; Geographic atrophy; Antiangiogenics; Degeneración macular asociada a la edad; AngiografÃa; TomografÃa de coherencia óptica; Neovascularización
Keywords: Ovarian cancer; Phase I trials; Precision medicine; Poly(ADP-ribose) Polymerase (PARP) inhibitors; Antiangiogenics; RMH prognostic score;
Original ResearchAdvanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. AÂ retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)
Keywords: Chordoma; Molecular targeted therapy; Imatinib; Antiangiogenics; Anti-EGFR; Prognostic factors;
Traitements médicaux des cholangiocarcinomes en 2015
Keywords: Antiangiogéniques; Anti-EGFR; Cancer des voies biliaires; Chimiothérapie; Cholangiocarcinome; Thérapies ciblées; Antiangiogenics; Anti-EGFR; Biliary tract carcinoma; Chemotherapy; Cholangiocarcinoma; Targeted therapies;
Monitoring vascular normalization induced by antiangiogenic treatment with 18F-fluoromisonidazole-PET
Keywords: Antiangiogenics; Vascular normalization; Biomarker; 18F-misonidazole-PET; Pancreatic cancer; Breast cancer;
Renal carcinoma pharmacogenomics and predictors of response: Steps toward treatment individualization
Keywords: Kidney cancer; Clear cell renal carcinoma; Targeted therapies; Predictive biomarkers; Antiangiogenics; mTOR inhibitors
Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy
Keywords: Antiangiogenics; Radiotherapy; Normalization window of oxygenation; Hypoxia;
Diffusion MR Imaging for Monitoring of Treatment Response
Keywords: Diffusion MR imaging; Biomarker; Cellularity; Functional imaging; Response monitoring; Radiotherapy; Antiangiogenics;
Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
Keywords: Breast cancer; Triple negative; Basal-like; Molecular features; Breast epithelium; Molecular targets; Platinum compounds; PARP inhibitors; EGFR inhibitors; Antiangiogenics
Inhibiteurs de l’angiogenèse et radiothérapie : du concept à la clinique
Keywords: Radiothérapie; Antiangiogéniques; Fenêtre de normalisation vasculaire; HypoxieRadiation therapy; Antiangiogenics; Normalization of tumour vasculature; Hypoxia